Kazuhiro Sako,Toyohiro Sawada,Hiromu Kondo,Keiichi Yoshihara,Hiroyuki Kojima
申请号：
US13329164
公开号：
US20120088838A1
申请日:
2011.12.16
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The present invention provides a sustained-release pharmaceutical composition, characterized in that there are contained tamsulosin or a pharmaceutically acceptable salt thereof and a carrier for a sustained-release pharmaceutical composition and the ratio (Cmin/Cmax ratio) of the plasma tamsulosin concentration at 24 hours after the administration of the preparation per os (Cmin) to the maximum plasma tamsulosin concentration after the administration (Cmax) is about 0.4 or more.
